Matrix metalloproteinase-13 in atherosclerotic plaque is increased by influenza A virus infection.
Influenza virus infection triggers acute cardiovascular events. Several studies have demonstrated that influenza A virus infection was associated with immune cell influx and increased production of inflammatory cytokines in the atherosclerotic plaque lesion, but the underlying mechanism for these findings is not clear. We examined the expression levels of matrix metalloproteinases by influenza A virus infection in human cells using quantitative RT-PCR, Western blot and human MMP-13 ELISA assay. In an animal study, protein expression in the plaque lesions of ApoE-deficient mice were analyzed by immunohistochemistry and Western blot. We confirmed that matrix metalloproteinase-13 was increased in influenza A virus-infected cells. In the aorta of infected ApoE-deficient mice, matrix metalloproteinase-13 was increased at 3 days after infection. Immunohistochemical staining results suggested that collagen was degraded in the matrix metalloproteinase-13 expression area and that macrophages were the main source of matrix metalloproteinase-13 expression. Furthermore, the expression of matrix metalloproteinase-13 was regulated by influenza A virus through activation of the p38 MAPK signal pathway. In this study, we demonstrated that p38 MAPK-mediated matrix metalloproteinase-13 expression by influenza A virus infection led to destabilization of vulnerable atherosclerotic plaques in artery. (191 words).